SEC Form 4 · Updated Daily
PLX
— PROTALIX BIOTHERAPEUTICS, INC. OwnershipInsider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| Rubin Eyal | Officer | 669,010 | 2024-09-23 | A |
| Naos Yaron | Officer | 225,817 | 2025-09-03 | A |
| Bashan Dror | Director · Officer | 188,516 | 2025-12-19 | P |
| Hayon Yael | Officer | 35,115 | 2023-08-15 | A |
| Boudes Pol F | Director | 7,500 | 2025-09-03 | A |
| Melincoff Gwen A | Director | 7,500 | 2025-09-03 | A |
| Schwartz Aharon | Director | 7,500 | 2025-09-03 | A |
| Forster Eliot | Director | 7,500 | 2025-09-03 | A |
| Ben Zvi Shmuel | Director | 7,500 | 2025-09-03 | A |
| Elze Christian | Director | 7,500 | 2025-09-03 | A |
| Bar-Shalev Amos | Director | 0 | 2025-11-18 | S |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2026-09-03 | Schwartz Aharon | Grant / award (derivative) | 8,500 | $0.00 | 8,500 |
| 2026-09-03 | Schwartz Aharon | Grant / award (derivative) | 17,000 | $0.00 | 17,000 |
| 2026-09-03 | Forster Eliot | Grant / award (derivative) | 8,500 | $0.00 | 8,500 |
| 2026-09-03 | Forster Eliot | Grant / award (derivative) | 17,000 | $0.00 | 17,000 |
| 2026-09-03 | Ben Zvi Shmuel | Grant / award (derivative) | 8,500 | $0.00 | 8,500 |
| 2026-09-03 | Ben Zvi Shmuel | Grant / award (derivative) | 17,000 | $0.00 | 17,000 |
| 2026-09-03 | Bar-Shalev Amos | Grant / award (derivative) | 8,500 | $0.00 | 8,500 |
| 2026-09-03 | Bar-Shalev Amos | Grant / award (derivative) | 17,000 | $0.00 | 17,000 |
| 2026-09-03 | Bashan Dror | Grant / award (derivative) | 160,000 | $0.00 | 160,000 |
| 2026-09-03 | Bashan Dror | Grant / award (derivative) | 320,000 | $0.00 | 320,000 |
| 2026-09-03 | Boudes Pol F | Grant / award (derivative) | 8,500 | $0.00 | 8,500 |
| 2026-09-03 | Boudes Pol F | Grant / award (derivative) | 17,000 | $0.00 | 17,000 |
| 2026-09-03 | Melincoff Gwen A | Grant / award (derivative) | 8,500 | $0.00 | 8,500 |
| 2026-09-03 | Melincoff Gwen A | Grant / award (derivative) | 17,000 | $0.00 | 17,000 |
| 2026-09-03 | Elze Christian | Grant / award (derivative) | 8,500 | $0.00 | 8,500 |
| 2026-09-03 | Elze Christian | Grant / award (derivative) | 17,000 | $0.00 | 17,000 |
| 2026-09-03 | Naos Yaron | Grant / award (derivative) | 56,000 | $0.00 | 56,000 |
| 2026-09-03 | Naos Yaron | Grant / award (derivative) | 112,000 | $0.00 | 112,000 |
| 2025-12-19 | Bashan Dror | Open-market buy | 56,000 | $1.81 | 188,516 |
| 2025-11-18 | Bar-Shalev Amos | Open-market sale | 168 | $1.87 | 0 |
| 2025-09-03 | Bashan Dror | Grant / award (derivative) | 340,000 | $0.00 | 340,000 |
| 2025-09-03 | Bashan Dror | Grant / award | 195,000 | — | 2,344,418 |
| 2025-09-03 | Naos Yaron | Grant / award (derivative) | 50,000 | $0.00 | 50,000 |
| 2025-09-03 | Naos Yaron | Grant / award | 25,000 | — | 225,817 |
| 2025-09-03 | Bar-Shalev Amos | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2025-09-03 | Bar-Shalev Amos | Grant / award | 7,500 | — | 7,500 |
| 2025-09-03 | Ben Zvi Shmuel | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2025-09-03 | Ben Zvi Shmuel | Grant / award | 7,500 | — | 7,500 |
| 2025-09-03 | Schwartz Aharon | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2025-09-03 | Schwartz Aharon | Grant / award | 7,500 | — | 7,500 |
| 2025-09-03 | Elze Christian | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2025-09-03 | Elze Christian | Grant / award | 7,500 | — | 7,500 |
| 2025-09-03 | Boudes Pol F | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2025-09-03 | Boudes Pol F | Grant / award | 7,500 | — | 7,500 |
| 2025-09-03 | Melincoff Gwen A | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2025-09-03 | Melincoff Gwen A | Grant / award | 7,500 | — | 7,500 |
| 2025-09-03 | Forster Eliot | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2025-09-03 | Forster Eliot | Grant / award | 7,500 | — | 7,500 |
| 2025-06-10 | Schwartz Aharon | Open-market buy | 129,000 | $1.60 | 303,000 |
| 2024-09-23 | Naos Yaron | Grant / award (derivative) | 100,000 | $0.00 | 100,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.